Chapter/Section Purchase

1 Study Coverage
1.1 Klebsiella Pneumoniae Infection Drug Product Introduction
1.2 Market by Type
1.2.1 Global Klebsiella Pneumoniae Infection Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 ATI-1503
1.2.3 CA-824
1.2.4 CC-1807
1.2.5 Cefiderocol
1.2.6 Debio-1454
1.2.7 EBX-004
1.2.8 Others
1.3 Market by Application
1.3.1 Global Klebsiella Pneumoniae Infection Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Klebsiella Pneumoniae Infection Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Klebsiella Pneumoniae Infection Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Klebsiella Pneumoniae Infection Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Klebsiella Pneumoniae Infection Drug Sales by Region
2.4.1 Global Klebsiella Pneumoniae Infection Drug Sales by Region (2017-2022)
2.4.2 Global Sales Klebsiella Pneumoniae Infection Drug by Region (2023-2028)
2.5 Global Klebsiella Pneumoniae Infection Drug Revenue by Region
2.5.1 Global Klebsiella Pneumoniae Infection Drug Revenue by Region (2017-2022)
2.5.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Klebsiella Pneumoniae Infection Drug Sales by Manufacturers
3.1.1 Global Top Klebsiella Pneumoniae Infection Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Klebsiella Pneumoniae Infection Drug in 2021
3.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Manufacturers
3.2.1 Global Klebsiella Pneumoniae Infection Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Klebsiella Pneumoniae Infection Drug Revenue in 2021
3.3 Global Klebsiella Pneumoniae Infection Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Klebsiella Pneumoniae Infection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Klebsiella Pneumoniae Infection Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Klebsiella Pneumoniae Infection Drug Sales by Type
4.1.1 Global Klebsiella Pneumoniae Infection Drug Historical Sales by Type (2017-2022)
4.1.2 Global Klebsiella Pneumoniae Infection Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2028)
4.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Type
4.2.1 Global Klebsiella Pneumoniae Infection Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Klebsiella Pneumoniae Infection Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Type (2017-2028)
4.3 Global Klebsiella Pneumoniae Infection Drug Price by Type
4.3.1 Global Klebsiella Pneumoniae Infection Drug Price by Type (2017-2022)
4.3.2 Global Klebsiella Pneumoniae Infection Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Klebsiella Pneumoniae Infection Drug Sales by Application
5.1.1 Global Klebsiella Pneumoniae Infection Drug Historical Sales by Application (2017-2022)
5.1.2 Global Klebsiella Pneumoniae Infection Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2028)
5.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Application
5.2.1 Global Klebsiella Pneumoniae Infection Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Klebsiella Pneumoniae Infection Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Application (2017-2028)
5.3 Global Klebsiella Pneumoniae Infection Drug Price by Application
5.3.1 Global Klebsiella Pneumoniae Infection Drug Price by Application (2017-2022)
5.3.2 Global Klebsiella Pneumoniae Infection Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Klebsiella Pneumoniae Infection Drug Market Size by Type
6.1.1 North America Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2028)
6.1.2 North America Klebsiella Pneumoniae Infection Drug Revenue by Type (2017-2028)
6.2 North America Klebsiella Pneumoniae Infection Drug Market Size by Application
6.2.1 North America Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2028)
6.2.2 North America Klebsiella Pneumoniae Infection Drug Revenue by Application (2017-2028)
6.3 North America Klebsiella Pneumoniae Infection Drug Market Size by Country
6.3.1 North America Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2028)
6.3.2 North America Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Klebsiella Pneumoniae Infection Drug Market Size by Type
7.1.1 Europe Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2028)
7.1.2 Europe Klebsiella Pneumoniae Infection Drug Revenue by Type (2017-2028)
7.2 Europe Klebsiella Pneumoniae Infection Drug Market Size by Application
7.2.1 Europe Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2028)
7.2.2 Europe Klebsiella Pneumoniae Infection Drug Revenue by Application (2017-2028)
7.3 Europe Klebsiella Pneumoniae Infection Drug Market Size by Country
7.3.1 Europe Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2028)
7.3.2 Europe Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Klebsiella Pneumoniae Infection Drug Market Size by Type
8.1.1 Asia Pacific Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Klebsiella Pneumoniae Infection Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Klebsiella Pneumoniae Infection Drug Market Size by Application
8.2.1 Asia Pacific Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Klebsiella Pneumoniae Infection Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Klebsiella Pneumoniae Infection Drug Market Size by Region
8.3.1 Asia Pacific Klebsiella Pneumoniae Infection Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Klebsiella Pneumoniae Infection Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Klebsiella Pneumoniae Infection Drug Market Size by Type
9.1.1 Latin America Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2028)
9.1.2 Latin America Klebsiella Pneumoniae Infection Drug Revenue by Type (2017-2028)
9.2 Latin America Klebsiella Pneumoniae Infection Drug Market Size by Application
9.2.1 Latin America Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2028)
9.2.2 Latin America Klebsiella Pneumoniae Infection Drug Revenue by Application (2017-2028)
9.3 Latin America Klebsiella Pneumoniae Infection Drug Market Size by Country
9.3.1 Latin America Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2028)
9.3.2 Latin America Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Klebsiella Pneumoniae Infection Drug Market Size by Type
10.1.1 Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Klebsiella Pneumoniae Infection Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Klebsiella Pneumoniae Infection Drug Market Size by Application
10.2.1 Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Klebsiella Pneumoniae Infection Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Klebsiella Pneumoniae Infection Drug Market Size by Country
10.3.1 Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Acies Bio doo
11.1.1 Acies Bio doo Corporation Information
11.1.2 Acies Bio doo Overview
11.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Acies Bio doo Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Acies Bio doo Recent Developments
11.2 Appili Therapeutics
11.2.1 Appili Therapeutics Corporation Information
11.2.2 Appili Therapeutics Overview
11.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Appili Therapeutics Recent Developments
11.3 Debiopharm International SA
11.3.1 Debiopharm International SA Corporation Information
11.3.2 Debiopharm International SA Overview
11.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Debiopharm International SA Recent Developments
11.4 Evaxion Biotech ApS
11.4.1 Evaxion Biotech ApS Corporation Information
11.4.2 Evaxion Biotech ApS Overview
11.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Evaxion Biotech ApS Recent Developments
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Corporation Information
11.5.2 F. Hoffmann-La Roche Ltd Overview
11.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 F. Hoffmann-La Roche Ltd Recent Developments
11.6 FOB Synthesis Inc
11.6.1 FOB Synthesis Inc Corporation Information
11.6.2 FOB Synthesis Inc Overview
11.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 FOB Synthesis Inc Recent Developments
11.7 ImmunoClin Corp
11.7.1 ImmunoClin Corp Corporation Information
11.7.2 ImmunoClin Corp Overview
11.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ImmunoClin Corp Recent Developments
11.8 Innovation Pharmaceuticals Inc
11.8.1 Innovation Pharmaceuticals Inc Corporation Information
11.8.2 Innovation Pharmaceuticals Inc Overview
11.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Innovation Pharmaceuticals Inc Recent Developments
11.9 Kyorin Pharmaceutical Co Ltd
11.9.1 Kyorin Pharmaceutical Co Ltd Corporation Information
11.9.2 Kyorin Pharmaceutical Co Ltd Overview
11.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Kyorin Pharmaceutical Co Ltd Recent Developments
11.10 Melinta Therapeutics Inc
11.10.1 Melinta Therapeutics Inc Corporation Information
11.10.2 Melinta Therapeutics Inc Overview
11.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Melinta Therapeutics Inc Recent Developments
11.11 Nosopharm SAS
11.11.1 Nosopharm SAS Corporation Information
11.11.2 Nosopharm SAS Overview
11.11.3 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Nosopharm SAS Recent Developments
11.12 Peptilogics Inc
11.12.1 Peptilogics Inc Corporation Information
11.12.2 Peptilogics Inc Overview
11.12.3 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Peptilogics Inc Recent Developments
11.13 Pfizer Inc
11.13.1 Pfizer Inc Corporation Information
11.13.2 Pfizer Inc Overview
11.13.3 Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Pfizer Inc Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Pfizer Inc Recent Developments
11.14 Phico Therapeutics Ltd
11.14.1 Phico Therapeutics Ltd Corporation Information
11.14.2 Phico Therapeutics Ltd Overview
11.14.3 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Phico Therapeutics Ltd Recent Developments
11.15 Sarepta Therapeutics Inc
11.15.1 Sarepta Therapeutics Inc Corporation Information
11.15.2 Sarepta Therapeutics Inc Overview
11.15.3 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Sarepta Therapeutics Inc Recent Developments
11.16 Shionogi & Co Ltd
11.16.1 Shionogi & Co Ltd Corporation Information
11.16.2 Shionogi & Co Ltd Overview
11.16.3 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Shionogi & Co Ltd Recent Developments
11.17 Syntiron LLC
11.17.1 Syntiron LLC Corporation Information
11.17.2 Syntiron LLC Overview
11.17.3 Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Syntiron LLC Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Syntiron LLC Recent Developments
11.18 Tetraphase Pharmaceuticals Inc
11.18.1 Tetraphase Pharmaceuticals Inc Corporation Information
11.18.2 Tetraphase Pharmaceuticals Inc Overview
11.18.3 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Tetraphase Pharmaceuticals Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Klebsiella Pneumoniae Infection Drug Industry Chain Analysis
12.2 Klebsiella Pneumoniae Infection Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Klebsiella Pneumoniae Infection Drug Production Mode & Process
12.4 Klebsiella Pneumoniae Infection Drug Sales and Marketing
12.4.1 Klebsiella Pneumoniae Infection Drug Sales Channels
12.4.2 Klebsiella Pneumoniae Infection Drug Distributors
12.5 Klebsiella Pneumoniae Infection Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Klebsiella Pneumoniae Infection Drug Industry Trends
13.2 Klebsiella Pneumoniae Infection Drug Market Drivers
13.3 Klebsiella Pneumoniae Infection Drug Market Challenges
13.4 Klebsiella Pneumoniae Infection Drug Market Restraints
14 Key Findings in The Global Klebsiella Pneumoniae Infection Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer